Biotherapeutics are a rapidly growing drug class in many diseases and include monoclonal antibodies and complex proteins that are produced in living cells. These complex molecules require precise development and measurement of yields, purity, potency, post-translational modifications (PTM) identification, along with quality control (QC) information at all stages to ensure successful manufacturability.

Just-Evotec Biologics’ have developed an approach to advance biotherapeutics from discovery to commercial manufacturing using our CHOSOURCE™ GS KO cell line in continuous perfusion bioreactors. In addition, for the characterization and QC of biotherapeutics throughout production, our LabChip^™ GXII Touch^™ can aid improved purity and performance.

In this webinar our speakers show:

• Just-Evotec Biologics’ integrated approach to antibody production in continuous perfusion bioreactors.
• Just-Evotec Biologics’ platform to design antibodies against infectious disease targets and expression of products using Revvity’s CHOSOURCE GS KO cell line.
• How Revvity’s LabChip GXII Touch can aid the measurement of biotherapeutic yields, purity and PTM identification for QC.

Speakers:

• Yiting Lim, PhD, Senior Scientist, Cell Line Development - Just-Evotec Biologics Inc
• Menel Ben Frej, PhD, Product Manager, Microfluidics Technology - Revvity

For research use only. Not for use in diagnostic procedures.